<VariationArchive VariationID="573009" VariationName="NM_001374353.1(GLI2):c.192dup (p.Asp65Ter)" VariationType="Duplication" Accession="VCV000573009" Version="5" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-28" DateCreated="2018-10-10" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="558707" VariationID="573009">
      <GeneList>
        <Gene Symbol="GLI2" FullName="GLI family zinc finger 2" GeneID="2736" HGNC_ID="HGNC:4318" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q14.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="120735868" stop="120992653" display_start="120735868" display_stop="120992653" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="121554866" stop="121750228" display_start="121554866" display_stop="121750228" Strand="+" />
          </Location>
          <OMIM>165230</OMIM>
          <Haploinsufficiency last_evaluated="2021-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GLI2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GLI2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001374353.1(GLI2):c.192dup (p.Asp65Ter)</Name>
      <CanonicalSPDI>NC_000002.12:120927402:TT:TTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2q14.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="120927402" stop="120927403" display_start="120927402" display_stop="120927403" variantLength="1" positionVCF="120927402" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="121684978" stop="121684979" display_start="121684978" display_stop="121684979" variantLength="1" positionVCF="121684978" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
      </Location>
      <ProteinChange>D65*</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.121684980dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.121684980dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.120927404dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.120927404dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009030.1" sequenceAccession="NG_009030" sequenceVersion="1" change="g.135114dup">
            <Expression>NG_009030.1:g.135114dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001371271.1" sequenceAccession="NM_001371271" sequenceVersion="1" change="c.192dup">
            <Expression>NM_001371271.1:c.192dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001358200.1" sequenceAccession="NP_001358200" sequenceVersion="1" change="p.Asp65Ter">
            <Expression>NP_001358200.1:p.Asp65Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374353.1" sequenceAccession="NM_001374353" sequenceVersion="1" change="c.192dup" MANESelect="true">
            <Expression>NM_001374353.1:c.192dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001361282.1" sequenceAccession="NP_001361282" sequenceVersion="1" change="p.Asp65Ter">
            <Expression>NP_001361282.1:p.Asp65Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005270.5" sequenceAccession="NM_005270" sequenceVersion="5" change="c.192dup">
            <Expression>NM_005270.5:c.192dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005261.2" sequenceAccession="NP_005261" sequenceVersion="2" change="p.Asp65Ter">
            <Expression>NP_005261.2:p.Asp65Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374354.1" sequenceAccession="NM_001374354" sequenceVersion="1" change="c.-121-23839dup">
            <Expression>NM_001374354.1:c.-121-23839dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005270.4" sequenceAccession="NM_005270" sequenceVersion="4" change="c.192dupT">
            <Expression>NM_005270.4:c.192dupT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1388607733" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001374353.1(GLI2):c.192dup (p.Asp65Ter) AND multiple conditions" Accession="RCV000694552" Version="5">
        <ClassifiedConditionList TraitSetID="19333">
          <ClassifiedCondition DB="MedGen" ID="C1835819">Holoprosencephaly 9</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4014479">Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-10-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-10-08" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-10-10" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14581620</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20685856</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="19333" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="13797" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome</ElementValue>
                <XRef ID="MONDO:0014369" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Culler-Jones syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CJS</ElementValue>
                <XRef Type="MIM" ID="615849" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PHS2</ElementValue>
                <XRef Type="MIM" ID="615849" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13349" />
                <XRef ID="13349" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="420584" DB="Orphanet" />
              <XRef ID="C4014479" DB="MedGen" />
              <XRef ID="MONDO:0014369" DB="MONDO" />
              <XRef Type="MIM" ID="615849" DB="OMIM" />
            </Trait>
            <Trait ID="5262" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Holoprosencephaly 9</ElementValue>
                <XRef ID="Holoprosencephaly+9/8564" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012563" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES</ElementValue>
                <XRef Type="MIM" ID="610829" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES</ElementValue>
                <XRef Type="MIM" ID="610829" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HPE9</ElementValue>
                <XRef Type="MIM" ID="610829" DB="OMIM" />
              </Symbol>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301702</ID>
                <ID Source="BookShelf">NBK1530</ID>
              </Citation>
              <XRef ID="2162" DB="Orphanet" />
              <XRef ID="C1835819" DB="MedGen" />
              <XRef ID="MONDO:0012563" DB="MONDO" />
              <XRef Type="MIM" ID="610829" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1594773" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2018-10-10">
        <ClinVarSubmissionID localKey="3849660|MedGen:C4014479;C1835819" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000823003" DateUpdated="2024-02-28" DateCreated="2018-10-10" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-10-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">14581620</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20685856</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in GLI2 are known to be pathogenic (PMID: 14581620, 20685856). This variant has not been reported in the literature in individuals with GLI2-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Asp65*) in the GLI2 gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GLI2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.121684978_121684979insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4014479" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1835819" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1594773" TraitType="Disease" MappingType="XRef" MappingValue="C1835819" MappingRef="MedGen">
        <MedGen CUI="C1835819" Name="Holoprosencephaly 9" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1594773" TraitType="Disease" MappingType="XRef" MappingValue="C4014479" MappingRef="MedGen">
        <MedGen CUI="C4014479" Name="Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

